e 4031 has been researched along with atropine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bracke, ME; De Ryck, T; Katritzky, AR; Patronov, A; Roman, BI; Slavov, SH; Stevens, CV; Vanhoecke, BW | 1 |
Limón, A; Pérez, C; Soto, E; Vega, R | 1 |
2 other study(ies) available for e 4031 and atropine
Article | Year |
---|---|
4-Fluoro-3',4',5'-trimethoxychalcone as a new anti-invasive agent. From discovery to initial validation in an in vivo metastasis model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biological Products; Cell Line, Tumor; Cell Movement; Cell Survival; Chalcones; Chick Embryo; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Discovery; Female; Humans; Mice; Mice, Nude; Molecular Structure; Myocardium; Neoplasm Invasiveness; Neoplasm Metastasis; Quantitative Structure-Activity Relationship | 2015 |
The muscarinic inhibition of the potassium M-current modulates the action-potential discharge in the vestibular primary-afferent neurons of the rat.
Topics: Action Potentials; Animals; Animals, Newborn; Anthracenes; Atropine; Biophysical Phenomena; Calcium Channel Blockers; Cells, Cultured; Indoles; Muscarinic Agonists; Muscarinic Antagonists; Neurons, Afferent; Oxotremorine; Patch-Clamp Techniques; Piperidines; Potassium Channel Blockers; Potassium Channels; Pyridines; Rats; Rats, Wistar; Receptors, Muscarinic; Vestibule, Labyrinth | 2009 |